triangle

About Us

Serimmune is an immune intelligence company focused on identifying and exploiting the universe of relationships between antibodies and antigens. Our proprietary technology provides a holistic view of the functional antibody repertoire to identify diverse immunogenic factors in disease and health. The company’s Serum Epitope Repertoire Analysis (SERA) technology platform combines a novel, random bacterial display peptide library with next generation sequencing, machine learning, and custom bioinformatics to reveal the many diverse antigens stimulating immunity. Serimmune’s human immunity map is a growing database that can be interrogated to fuel the development of multiplex diagnostics, vaccines and therapeutics.

triangle

Leadership

Noah
Nasser

Chief Executive Officer

JOHN
SHON, MD, MS

Chief Technology Officer

KATHY
KAMATH, PhD

Sr. Director, R&D

HEIDI
SMITH

VP, Finance & Controller

PATRICK
DAUGHERTY, PhD

Founder, Scientific Advisor

Board of Directors

NOAH
NASSER

CEO, Serimmune

NICK
NACLERIO, PhD

Founding Partner, Illumina Ventures

BILL
WELCH, MBA

Partner, Illumina Ventures

KRISTIN
LOOMIS, MBA

President & Executive Director,
HHV-6 Foundation

PATRICK
DAUGHERTY, PhD

Founder & CSO, Serimmune

Scientific Advisory Board

ELITZA
THEEL, PhD

Mayo Clinic

FELIX
FENG, MD

UCSF

ANTHONY
KOMAROFF, MD

BWH Harvard

ANSHUL
KUNDAJE, PhD

Stanford

PATRICK
DAUGHERTY, PhD

UCSB (Faculty alum)

triangles

Investors